STOCK THE BANK

Houston Food Bank seeks volunteers for coronavirus quarantine kits

The Food Bank needs help packing quarantine food kits. Photo courtesy of Houston Food Bank

As the long lines at any local Costco suggest, the coronavirus/COVID 19 phenomenon has caused some to interpret news reports advising sensible precautions such as "wash your hands thoroughly" to mean "buy a car-full of toilet paper."

Talk of a potential quarantine has only added to the fervor, as citizens are advised to stock up on food for up to two weeks. But what of those who can't don masks and charge through sprawling stores looking for tuna packets?

The Houston Food Bank is asking that local residents assist those who do not have reserves of food in the event of service disruptions and closures. The non-profit has put out a call for volunteers to help pack essential quarantine food kits. The boxes are not yet being requested, but will be necessary in the event there is a need due to COVID-19 occurrences in their service area, according to the Food Bank.

"Hundreds of thousands of people are counting on the organization and its partners now, and this need will only heighten if the COVID-19 situation worsens," says Brian Greene, president/CEO of Houston Food Bank.

Volunteers can sign up for shifts online to help pack these boxes at the Food Bank, 535 Portwall St. Volunteer shifts run from 8 am to noon Monday–Saturday, from 6 pm to 9 pm Monday–Friday, and from 9 am to noon Sunday.

To quell any obvious concerns about safety, the Food Bank has increased the frequency of cleaning and disinfecting, especially around high-traffic areas, such as volunteer areas, elevators, meeting rooms, bathrooms, food areas.

Greene also notes that volunteers can bring much-needed items to donate and pack. The Food Bank's most-needed items include:

  • Rice
  • Pasta
  • Peanut butter
  • Canned protein
  • Soups
  • Jelly
  • Nutritious snacks
  • Canned Vegetable
  • Canned fruit
  • Hygiene items
  • Cleaning supplies: paper towels, disinfectant, bleach wipes
  • Bottled water

And, says Greene, "a little something sweet like cookies never hurt."

------

This article originally ran on CultureMap.

Trending News

Building Houston

 
 

BiVACOR has received fresh funding from its investors to further develop its artificial heart. Photo courtesy of BiVACOR

A Houston medical device company that is developing an artificial heart announced it has received investment funding to the tune of $18 million.

BiVACOR's investment round was led by Boston-based Cormorant Asset Management and Australia's OneVentures's Healthcare Fund III. According to the company, the funding will be deployed to continue research and development, hiring executives, and support the path to first in human trials.

“We are extremely grateful for the ongoing support from our core investors," says Thomas Vassiliades, who was named CEO of BiVACOR last year, in a news release. "This additional commitment further validates our technology and the need for improved options to treat end-stage biventricular heart failure.

“With this financing, we will be able to double the size of our organization and add key positions from the C-suite to research and development. We are well positioned to advance our preclinical activities and aim to conduct our First in Human early feasibility study planned for the end of the year,” he continues.

Billed as the first long-term treatment for patients with severe biventricular heart failure, the BiVACOR Total Artificial Heart is an implantable artificial heart that utilizes rotary blood pump technology. This technology includes magnetic levitation and is a "durable, reliable, and biocompatible heart replacement," per the company's release. It's about the size of a fist and can be used in a wide range of patients including some children and women and up to adult males.

“Under the leadership of its expert management team, the company has developed a credible strategy for growth as they march toward first in human studies,” says Jeannie Joughin, board chair and principal at One Ventures, in the release. “There is a huge gap in care for patients waiting for a heart transplant, and we are confident that BiVACOR will continue to execute its strategy to swiftly get the Total Artificial Heart into the patients who need it most.”

The company raised its $22 million series B round in early 2021, which was also led by Cormorant Asset Management and OneVentures. To date, BiVACOR has raised $60 million.

“BiVACOR continues to execute on its strategy, and there was no question that we would jump in to lead this funding,” says Bihua Chen, CEO and founder of Cormorant Asset Management. “We are impressed by BiVACOR’s world-class team and continued dedication to push the technology in the clinic. We’re excited to support their growth and vision to transform the treatment of biventricular heart failure with the world’s first fully MAGLEV total artificial heart.”

Founded in 2008, BiVACOR maintains offices in Cerritos, California, and Brisbane, Australia. The company is affiliated with Houston's Texas Heart Institute, where the world's first artificial heart was implanted. BiVACOR's headquarters is at the Texas Medical Center complex.

Trending News